Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abundant, aimed, ASC, ASU, automation, budgetary, category, chelated, cohort, commensurate, composite, condensed, consecutive, convergence, corrected, correction, Department, discarded, diversification, emphasizing, error, flexibility, GlaxoSmithKline, graft, Haematologica, hedging, host, hundred, immaterial, indirectly, insensitive, instantaneously, magnitude, manipulating, Memorial, metabolite, mucin, nineteen, nonowner, notification, notified, oral, OS, overstatement, pattern, physically, poor, proceed, proper, proportionate, QTDP, raw, retreated, retreatment, Roche, routinely, saline, scale, solubility, solution, statistical, strong, Takeda, turnover, unchanged, understatement, unnecessary, USP, virtually, VSOE
Removed:
AG, anniversary, assign, attrition, bond, buyer, buying, classification, COBRA, collected, coupon, dental, desire, differentiating, direct, dutch, entrance, estate, Euro, evaluable, excise, executed, expending, factor, follicular, foregoing, frequency, frequent, Genentech, Glaxo, hour, Ib, ibritumomab, inaccurate, incidence, infusion, insuring, internalizing, liquidate, liquidating, lump, mab, mCi, Medarex, monetize, multicenter, mutually, ninety, offered, parental, Pharma, premium, preparing, prevented, prorated, purified, purity, rating, replenishment, ribonuclease, route, satisfy, Schering, seeking, sentiment, settling, showed, SmithKline, split, stabilization, subgroup, successive, surrender, tiuxetan, uptake, utilized, vitro
Filing tables
Filing exhibits
- 10-K Annual report
- 10.35 Sixth Amendment Extension Agreement Dated February 11, 2011
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Independent Registered Public Accounting Firm - Ernst & Young LLP
- 31.1 Certification of the Chief Executive Officer Pursuant to Section 302(A)
- 31.2 Certification of the Chief Financial Officer Pursuant to Section 302(A)
- 32.1 Certification of the Chief Executive Officer Pursuant to Section 906
- 32.2 Certification of the Chief Financial Officer Pursuant to Section 906
Related press release
IMMU similar filings
Filing view
External links